Y. Cheng

发表

Prognostic value of nodal ratios in node-positive breast cancer.

W. Woodward, G. Hortobagyi, G. Vlastos, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The future of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinoma in the era of target-specific therapy

N. Ueno, Y. Cheng, 2006, Bone Marrow Transplantation.

Diet-induced obesity links to ER positive breast cancer progression via LPA/PKD-1-CD36 signaling-mediated microvascular remodeling

Shiyong Wu, B. Ren, R. Silverstein, 2017, Oncotarget.

Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumors.

G. Hortobagyi, E. Jonasch, D. Booser, 2003, Blood.

Improvement of survival and prospect of cure in patients with metastatic breast cancer

N. Ueno, Y. Cheng, 2012, Breast Cancer.

Androgen receptor expression in patients with triple negative breast cancer treated with neoadjuvant chemotherapy: a single institution study

C. Glisch, J. Charlson, J. Jorns, 2022, Journal of Cancer.

Natural history of metastatic renal cell carcinoma in patients who underwent consultation for allogeneic hematopoietic stem cell transplantation.

J. Wathen, N. Ueno, R. Champlin, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Successful treatment of aggressive HIV-associated multicentric Castleman's disease: a case report.

Y. Cheng, Magdalena Flejsierowicz, Mohamed S. Ahmed, 2008, WMJ : official publication of the State Medical Society of Wisconsin.

Low prevalence of premature ovarian failure in women given reduced-intensity conditioning regimens for hematopoietic stem-cell transplantation.

D. Bodurka, N. Ueno, K. Lu, 2005, Haematologica.

Long-Term Outcome of Inflammatory Breast Cancer Compared to Non-Inflammatory Breast Cancer in the Setting of High-Dose Chemotherapy with Autologous Hematopoietic Cell Transplantation

P. Hari, N. Ueno, R. Gale, 2017, Journal of Cancer.

High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation in Inflammatory Breast Cancer

N. Ueno, Y. Cheng, 2012 .

Long-term remission with imatinib mesylate in Philadelphia chromosome-positive AML presenting as primary extramedullary myeloid sarcoma.

D. King, S. Kroft, Y. Cheng, 2008, Leukemia research.

The use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic stem cell transplantation as consolidation therapy for high-risk primary breast cancer after primary surgery or neoadjuvant chemotherapy.

G. Hortobagyi, E. Shpall, N. Ueno, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Metaplastic Breast Cancer: Characteristics and Survival Outcomes

Jia Xuefei, T. Spiro, H. Daw, 2022, Cureus.

Phase II study of gonadotropin-releasing hormone analog for ovarian function preservation in hematopoietic stem cell transplantation patients.

A. Milbourne, N. Ueno, R. Champlin, 2012, The oncologist.

disease Prompt versus preemptive intervention for EBV lymphoproliferative

H. Heslop, C. Rooney, A. Gee, 2013 .

Primary mediastinal embryonal carcinoma masquerading as chronic pancreatitis.

Hongyung Choi, D. Teves, Y. Cheng, 2007, WMJ : official publication of the State Medical Society of Wisconsin.

Prompt versus preemptive intervention for EBV lymphoproliferative disease.

R. Krance, H. Heslop, C. Rooney, 2004, Blood.

Carboplatin and docetaxel-induced acute pancreatitis: brief report

S. Devata, Y. Cheng, V. Singh, 2010, International Journal of Clinical Oncology.